• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对儿童炎症性肠病中T细胞 trafficking 的机会。 (注:这里“trafficking”结合语境可能是“运输、游走、归巢等相关意思,具体准确意思需结合完整文献确定)

Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.

作者信息

Giannoudaki Eirini, Gargan Siobhan, Hussey Seamus, Long Aideen, Walsh Patrick T

机构信息

National Children's Research Center, Children's Health Ireland (CHI) Crumlin, Dublin, Ireland.

Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland.

出版信息

Front Pediatr. 2021 Mar 18;9:640497. doi: 10.3389/fped.2021.640497. eCollection 2021.

DOI:10.3389/fped.2021.640497
PMID:33816403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8012547/
Abstract

T cell subsets are considered central orchestrators of inflammation and homeostasis in the intestine and are established targets for the treatment of inflammatory bowel disease. While approaches aimed at the neutralization of T cell effector cytokines have provided significant benefits for pediatric and adult patients, more recent strategies aimed at inhibiting the infiltration of pathogenic T cell subsets have also emerged. In this review, we describe current knowledge surrounding the function of T cell subsets in pediatric inflammatory bowel disease and outline approaches aimed at targeting T cell trafficking to the intestine which may represent a new treatment option for pediatric inflammatory bowel disease.

摘要

T细胞亚群被认为是肠道炎症和内环境稳态的核心调节者,也是治疗炎症性肠病的既定靶点。虽然旨在中和T细胞效应细胞因子的方法已为儿科和成年患者带来显著益处,但最近旨在抑制致病性T细胞亚群浸润的策略也已出现。在本综述中,我们描述了目前关于儿科炎症性肠病中T细胞亚群功能的知识,并概述了旨在靶向T细胞向肠道迁移的方法,这可能代表了儿科炎症性肠病的一种新治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/8012547/93c9347c2547/fped-09-640497-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/8012547/93c9347c2547/fped-09-640497-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/387a/8012547/93c9347c2547/fped-09-640497-g0001.jpg

相似文献

1
Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease.针对儿童炎症性肠病中T细胞 trafficking 的机会。 (注:这里“trafficking”结合语境可能是“运输、游走、归巢等相关意思,具体准确意思需结合完整文献确定)
Front Pediatr. 2021 Mar 18;9:640497. doi: 10.3389/fped.2021.640497. eCollection 2021.
2
Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.溃疡性结肠炎或克罗恩病患者血液中幼稚、激活和记忆 T 及 B 细胞的不同模式。
Clin Exp Immunol. 2019 Jul;197(1):111-129. doi: 10.1111/cei.13294. Epub 2019 Apr 8.
3
Manipulation of cytokines in the management of patients with inflammatory bowel disease.炎症性肠病患者管理中细胞因子的调控
Ann Med. 2000 Nov;32(8):552-60. doi: 10.3109/07853890008998835.
4
Diagnostic problems and advances in inflammatory bowel disease.炎症性肠病的诊断问题与进展
Mod Pathol. 2003 Apr;16(4):347-58. doi: 10.1097/01.MP.0000064746.82024.D1.
5
Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.炎症的系统分子介质可区分克罗恩病和溃疡性结肠炎,提示 IL-10 的阈值水平和治疗中促炎细胞因子的相对比值。
J Crohns Colitis. 2020 Jan 1;14(1):118-129. doi: 10.1093/ecco-jcc/jjz117.
6
Biologic therapy for inflammatory bowel disease.炎症性肠病的生物治疗
Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002.
7
Cytokine production in patients with inflammatory bowel disease.炎症性肠病患者的细胞因子产生
Gut. 1992 Jul;33(7):933-7. doi: 10.1136/gut.33.7.933.
8
INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.白细胞介素-6、C反应蛋白与白细胞介素-6(-174)G/C多态性在克罗恩病和溃疡性结肠炎发病机制中的相互作用
Acta Clin Croat. 2020 Mar;59(1):67-80. doi: 10.20471/acc.2020.59.01.09.
9
Immune system alterations in patients with inflammatory bowel disease during remission.炎症性肠病缓解期患者的免疫系统改变
Medicina (Kaunas). 2008;44(1):27-33.
10
Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases.磁共振成像用于鉴别儿童炎症性肠病的类型和严重程度。
J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):170-4. doi: 10.1097/00005176-200002000-00014.

引用本文的文献

1
Pediatric IBD patients show medication and disease activity dependent changes in NK cell and CD4 memory T cell populations.儿科炎症性肠病患者的自然杀伤细胞和CD4记忆性T细胞群体呈现出药物和疾病活动依赖性变化。
Front Pediatr. 2023 Jun 29;11:1123873. doi: 10.3389/fped.2023.1123873. eCollection 2023.
2
The Immune Landscape and Molecular Subtypes of Pediatric Crohn's Disease: Results from In Silico Analysis.儿童克罗恩病的免疫格局与分子亚型:计算机模拟分析结果
J Pers Med. 2023 Mar 23;13(4):571. doi: 10.3390/jpm13040571.
3
IL-36 cytokines imprint a colitogenic phenotype on CD4 T helper cells.

本文引用的文献

1
The Many Functions of Foxp3 Regulatory T Cells in the Intestine.Foxp3+ 调节性 T 细胞在肠道中的多种功能。
Front Immunol. 2020 Oct 20;11:600973. doi: 10.3389/fimmu.2020.600973. eCollection 2020.
2
Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease.炎症性肠病患儿血清白介素 17A 和白介素 17F。
Sci Rep. 2020 Jul 28;10(1):12617. doi: 10.1038/s41598-020-69567-x.
3
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways.儿科发病期结肠炎和炎症性肠病的黏膜剖析揭示了常见的发病机制和治疗途径。
白细胞介素-36 细胞因子在 CD4 T 辅助细胞上印刻结肠炎表型。
Mucosal Immunol. 2022 Mar;15(3):491-503. doi: 10.1038/s41385-022-00488-w. Epub 2022 Feb 17.
Cell. 2019 Nov 14;179(5):1160-1176.e24. doi: 10.1016/j.cell.2019.10.027.
4
Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease.儿童炎症性肠病的当前概念;以IL10/IL10R结肠炎作为模型疾病
Int J Pediatr Adolesc Med. 2019 Mar;6(1):1-5. doi: 10.1016/j.ijpam.2019.02.002. Epub 2019 Mar 12.
5
Upper gastrointestinal tract involvement of pediatric inflammatory bowel disease: A pathological review.小儿炎症性肠病的上消化道受累:病理评价。
World J Gastroenterol. 2019 Apr 28;25(16):1928-1935. doi: 10.3748/wjg.v25.i16.1928.
6
The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.丹麦和芬兰 23 年间儿科发病炎症性肠病的癌症发病率和死亡率:一项基于人群的研究。
Aliment Pharmacol Ther. 2019 Jul;50(1):33-39. doi: 10.1111/apt.15258. Epub 2019 May 8.
7
Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.溃疡性结肠炎或克罗恩病患者血液中幼稚、激活和记忆 T 及 B 细胞的不同模式。
Clin Exp Immunol. 2019 Jul;197(1):111-129. doi: 10.1111/cei.13294. Epub 2019 Apr 8.
8
Mucosal Immunity Related to FOXP3 Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中与 FOXP3 调节性 T 细胞、Th17 细胞和细胞因子相关的黏膜免疫。
J Korean Med Sci. 2018 Dec 10;33(52):e336. doi: 10.3346/jkms.2018.33.e336. eCollection 2018 Dec 24.
9
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.阿柏西普治疗中重度溃疡性结肠炎的随机、安慰剂对照试验的疗效和安全性。
Gastroenterology. 2019 Mar;156(4):946-957.e18. doi: 10.1053/j.gastro.2018.11.035. Epub 2018 Nov 23.
10
Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.与普通人群相比,儿童期发病的炎症性肠病患者的死亡率增加。
Gastroenterology. 2019 Feb;156(3):614-622. doi: 10.1053/j.gastro.2018.10.028. Epub 2018 Oct 17.